MiNK Therapeutics Stock (NASDAQ: INKT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 156.54K |
Day Range | - - - |
52 Wk Range | 0.75 - 1.96 |
Market Cap | $33.87M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 0.65% |
Days to Cover | 2.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MiNK Therapeutics (NASDAQ:INKT) through any online brokerage.
Other companies in MiNK Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), Curis (NASDAQ:CRIS) and Immuneering (NASDAQ:IMRX).
There is no analysis for MiNK Therapeutics.
MiNK Therapeutics has a consensus price target of $12.00.
The stock price for MiNK Therapeutics (NASDAQ: INKT) is $0.8603 last updated July 19, 2024 at 7:40 PM EDT.
There are no upcoming dividends for MiNK Therapeutics.
MiNK Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for MiNK Therapeutics.
MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.